Interleukin-32 in systemic sclerosis, a potential new biomarker for pulmonary arterial hypertension

Interleukin-32 in systemic sclerosis, a potential new biomarker for pulmonary arterial hypertension

Abstract Background Pulmonary arterial hypertension (PAH) is a severe complication of systemic sclerosis (SSc), associated with a progressive elevation in pulmonary vascular resistance and subsequent right heart failure and death. Due to unspecific symptoms, the diagnosis of PAH is often delayed. On...

Full description

Bibliographic Details
Main Authors: Paola Di Benedetto, Giuliana Guggino, Giovanna Manzi, Piero Ruscitti, Onorina Berardicurti, Noemi Panzera, Nicolò Grazia, Roberto Badagliacca, Valeria Riccieri, Carmine Dario Vizza, Ganna Radchenko, Vasiliki Liakouli, Francesco Ciccia, Paola Cipriani, Roberto Giacomelli
Format: Article
Language:English
Published: BMC 2020-06-01
Series:Arthritis Research & Therapy
Subjects:
Systemic sclerosis
Pulmonary arterial hypertension
IL-32
Online Access:http://link.springer.com/article/10.1186/s13075-020-02218-8

Internet

http://link.springer.com/article/10.1186/s13075-020-02218-8

Similar Items